Video

How Do Emerging Infectious Diseases Affect National Security and Policy Discussions?

Author(s):

Amesh Adalja, MD, UPMC Center for National Security and his colleagues study recent outbreaks and work on how to better prepare the country for outbreaks like this in the future.

Amesh Adalja, MD, UPMC Center for National Security and his colleagues study recent outbreaks and work on how to better prepare the country for outbreaks like this in the future. At IDWeek 2016, Adalja explained that his team looked at non-traditional approaches as in rather scrutinizing ordinary antibiotics when you have ore and more resistance, he was "thinking about changing the whole game and going into more specific targeted therapies". He wanted to look at what's the case for bacterial phages, and question how would one facilitate the use of those in clinical settings. "We're taking what's going on in the scientific world and bridging it into the clinical and policy worlds," said Adalja.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.